Brown Capital Management LLC Cytek Biosciences, Inc. Transaction History
Brown Capital Management LLC
- $4.88 Billion
- Q2 2024
A detailed history of Brown Capital Management LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Brown Capital Management LLC holds 11,387,384 shares of CTKB stock, worth $59.2 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
11,387,384
Previous 12,022,014
5.28%
Holding current value
$59.2 Million
Previous $80.7 Million
21.23%
% of portfolio
1.3%
Previous 1.45%
Shares
8 transactions
Others Institutions Holding CTKB
# of Institutions
135Shares Held
73.9MCall Options Held
200Put Options Held
100-
Black Rock Inc. New York, NY17.1MShares$88.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$61.1 Million0.0% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$34.6 Million0.96% of portfolio
-
State Street Corp Boston, MA3.97MShares$20.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.58MShares$13.4 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $700M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...